Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Hupperts

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Journal of Proteome Research|July 11, 2006
Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometryJean-Paul Noben, Debora Dumont, Natalia Kwasnikowska, et al.
European Journal of Neurology|December 16, 2020
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosisMax Mimpen, Anne-Hilde Muris, Linda Rolf, et al.
Journal of Neuroimmunology|November 1, 2011
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapseEvelyn Peelen, Jan Damoiseaux, Joost Smolders, et al.
Therapeutic Advances in Neurological Disorders|May 23, 2022
Efficacy of prolonged-release fampridine <i>versus</i> placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCERaymond Hupperts, Claudio Gasperini, Jan Lycke, et al.
Cells|October 17, 2019
From OPC to Oligodendrocyte: An Epigenetic JourneyAssia Tiane, Melissa Schepers, Ben Rombaut, et al.
Journal of Neuroimmunology|September 24, 2011
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remissionStephanie Knippenberg, Evelyn Peelen, Joost Smolders, et al.
Immunology|September 28, 2007
Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell levelKoen Venken, Niels Hellings, Marielle Thewissen, et al.
Autoimmunity Reviews|May 31, 2011
Effects of vitamin D on the peripheral adaptive immune system: a reviewEvelyn Peelen, Stephanie Knippenberg, Anne-Hilde Muris, et al.
Plos One|November 1, 2014
Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up studyNele Claes, Tessa Dhaeze, Judith Fraussen, et al.
Journal of Neuroimmunology|April 22, 2011
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosisJoost Smolders, Mariëlle Thewissen, Ruud Theunissen, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Journal of Proteome Research|July 11, 2006
Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometryJean-Paul Noben, Debora Dumont, Natalia Kwasnikowska, et al.
European Journal of Neurology|December 16, 2020
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosisMax Mimpen, Anne-Hilde Muris, Linda Rolf, et al.
Journal of Neuroimmunology|November 1, 2011
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapseEvelyn Peelen, Jan Damoiseaux, Joost Smolders, et al.
Therapeutic Advances in Neurological Disorders|May 23, 2022
Efficacy of prolonged-release fampridine <i>versus</i> placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCERaymond Hupperts, Claudio Gasperini, Jan Lycke, et al.
Cells|October 17, 2019
From OPC to Oligodendrocyte: An Epigenetic JourneyAssia Tiane, Melissa Schepers, Ben Rombaut, et al.
Journal of Neuroimmunology|September 24, 2011
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remissionStephanie Knippenberg, Evelyn Peelen, Joost Smolders, et al.
Immunology|September 28, 2007
Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell levelKoen Venken, Niels Hellings, Marielle Thewissen, et al.
Autoimmunity Reviews|May 31, 2011
Effects of vitamin D on the peripheral adaptive immune system: a reviewEvelyn Peelen, Stephanie Knippenberg, Anne-Hilde Muris, et al.
Plos One|November 1, 2014
Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up studyNele Claes, Tessa Dhaeze, Judith Fraussen, et al.
Journal of Neuroimmunology|April 22, 2011
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosisJoost Smolders, Mariëlle Thewissen, Ruud Theunissen, et al.
Pageof 12